68 Ga-FAPI PET/CT Outperforms FDG PET/CT in the Early Detection of the Carcinoma Gall Bladder
Indian Journal of Nuclear Medicine · 20.05.2026 · 41 · 417-419
DOI: 10.25259/ijnm_127_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 20.05.2026. Verfasst von Barkha Pal und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Gallbladder carcinoma contributes 50% of biliary tract cancers. Its gradual onset and nonspecific early symptoms often delay diagnosis, making early detection and treatment vital for better outcomes. 68 Ga-labelled fibroblast activation protein inhibitor (FAPI), an emerging positron emission tomography (PET) tracer, has demonstrated its diagnostic superiority over 18 F-fluorodeoxyglucose PET/computed tomography ( 18 F-FDG PET/CT) in the detection of primary and metastatic lesions across various malignancies. Here, our case represents the superiority of 68 Ga FAPI PET/CT over the 18 F-FDG PET/CT scan in the detection of the carcinoma gallbladder.
Zitieren
APA
Pal, B., Dhull, V. S., Lele, V. R., Vaswani, G., & Rathodkar, N. B. (2026). 68 Ga-FAPI PET/CT Outperforms FDG PET/CT in the Early Detection of the Carcinoma Gall Bladder. Indian Journal of Nuclear Medicine, 41, 417-419. https://doi.org/10.25259/ijnm_127_25
Vancouver
Pal B, Dhull VS, Lele VR, Vaswani G, Rathodkar NB. 68 Ga-FAPI PET/CT Outperforms FDG PET/CT in the Early Detection of the Carcinoma Gall Bladder. Indian Journal of Nuclear Medicine. 2026;41:417-419. doi:10.25259/ijnm_127_25
BibTeX
@article{Pal2026,
author = {Pal, Barkha and Dhull, Varun Singh and Lele, Vikram R and Vaswani, Girish and Rathodkar, Neha Balkrishna},
title = {68 Ga-FAPI PET/CT Outperforms FDG PET/CT in the Early Detection of the Carcinoma Gall Bladder},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {41},
pages = {417--419},
doi = {10.25259/ijnm_127_25}
}
EUVIMED